Sydney, Australia, May 2019 AMSL Diabetes are excited to announce that they have signed a distribution agreement with MannKind Corporation (NASDAQ: MNKD) to introduce their patient-focused therapies to the Australian market. The exclusive partnership is set to benefit Australian diabetes patients by offering a new innovative technology solution for their diabetes management. “We are excited …
Continue reading "AMSL Diabetes Partner with MannKind Corporation"
17.05.2019
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
We are always happy to help, send us a message or enquiry